We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.5B
AUM Growth
-$232M
Cap. Flow
-$540M
Cap. Flow %
-2.92%
Top 10 Hldgs %
27.76%
Holding
3,069
New
24
Increased
234
Reduced
2,759
Closed
38

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$41.7M
2
DOCU
DocuSign
DOCU
+$18.2M
3
APO icon
Apollo Global Management
APO
+$17.5M
4
FLEX icon
Flex
FLEX
+$16.1M
5
WDAY icon
Workday
WDAY
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 29.77%
2 Financials 13.35%
3 Consumer Discretionary 11.87%
4 Industrials 10.17%
5 Healthcare 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKL icon
2151
Markel Group
MKL
$22.1B
$211K ﹤0.01%
122
-9
-7% -$14.9K
CHPT icon
2152
ChargePoint
CHPT
$243M
$211K ﹤0.01%
9,837
-541
-5% -$13.4K
HCAT icon
2153
Health Catalyst
HCAT
$128M
$210K ﹤0.01%
29,753
-1,485
-5% -$11.8K
LIF
2154
Life360
LIF
$3.48B
$210K ﹤0.01%
5,092
+1,987
+64% +$87.5K
FC icon
2155
Franklin Covey
FC
$203M
$210K ﹤0.01%
5,587
-422
-7% -$16.2K
SVC
2156
Service Properties Trust
SVC
$881M
$208K ﹤0.01%
16,405
-2,542
-13% -$41.1K
FNKO icon
2157
Funko
FNKO
$306M
$208K ﹤0.01%
15,535
-1,172
-7% -$13.8K
DDD icon
2158
3D Systems Corp
DDD
$552M
$208K ﹤0.01%
63,342
-4,782
-7% -$15.2K
BATRA icon
2159
Atlanta Braves Holdings Series A
BATRA
$3.47B
$208K ﹤0.01%
5,088
-384
-7% -$16.2K
UIS icon
2160
Unisys
UIS
$176M
$207K ﹤0.01%
32,736
-2,472
-7% -$17.2K
ESPR
2161
DELISTED
Esperion Therapeutics
ESPR
$207K ﹤0.01%
93,944
-7,091
-7% -$16.5K
MEI icon
2162
Methode Electronics
MEI
$522M
$207K ﹤0.01%
17,523
-1,323
-7% -$14.4K
NRIM icon
2163
Northrim BanCorp
NRIM
$582M
$206K ﹤0.01%
10,584
-800
-7% -$15.3K
HPP
2164
Hudson Pacific Properties
HPP
$664M
$206K ﹤0.01%
9,714
-1,526
-14% -$41.7K
FISI icon
2165
Financial Institutions
FISI
$806M
$206K ﹤0.01%
7,547
-569
-7% -$15K
ATXS
2166
DELISTED
Astria Therapeutics
ATXS
$206K ﹤0.01%
23,008
-1,073
-4% -$11.4K
YUMC icon
2167
Yum China
YUMC
$14.4B
$206K ﹤0.01%
4,270
-665
-13% -$31.5K
BOW
2168
Bowhead Specialty Holdings
BOW
$1.11B
$206K ﹤0.01%
5,787
+1,926
+50% +$63.2K
LINC icon
2169
Lincoln Educational Services
LINC
$794M
$205K ﹤0.01%
12,981
-980
-7% -$14.2K
WRLD icon
2170
World Acceptance Corp
WRLD
$890M
$205K ﹤0.01%
1,826
-144
-7% -$16.8K
URGN icon
2171
UroGen Pharma
URGN
$2.07B
$205K ﹤0.01%
19,237
-988
-5% -$11.8K
PPTA
2172
Perpetua Resources
PPTA
$2.96B
$204K ﹤0.01%
19,146
-1,445
-7% -$14.8K
DHIL
2173
DELISTED
Diamond Hill
DHIL
$204K ﹤0.01%
1,315
-99
-7% -$15.8K
SPFI icon
2174
South Plains Financial
SPFI
$843M
$203K ﹤0.01%
5,855
-442
-7% -$16K
FRPH icon
2175
FRP Holdings
FRPH
$425M
$203K ﹤0.01%
6,626
-500
-7% -$15.3K

Similar funds

Corebridge Financial's Q4 2024 Portfolio in Review

As of Q4 2024, Corebridge Financial held 3,069 positions worth $18.5B, down 1.2% from $18.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 2%. Corebridge Financial opened 24 new positions and exited 38, leaving the 3,069-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corebridge Financial's largest Q4 2024 buy was Apollo Global Management: 110,177 shares worth $18.2M.
  • Corebridge Financial added most to iShares MSCI EAFE ETF in Q4 2024, an estimated $41.7M increase.
  • Corebridge Financial's biggest Q4 2024 reduction was Apple, cutting an estimated $36.8M.
  • Corebridge Financial fully exited Southwestern Energy Company in Q4 2024, selling an estimated $9.27M.
  • Corebridge Financial's ten largest holdings make up 28% of its $18.5B portfolio in Q4 2024.
  • Corebridge Financial opened 24 new positions and closed 38 in Q4 2024.
  • Corebridge Financial's portfolio value fell 1.2% quarter-over-quarter to $18.5B.

Based on Corebridge Financial's 13F filing for Q4 2024, filed 11 Feb 2025.